Welcome to Sott.net
Tue, 19 Oct 2021
The World for People who Think

Health & Wellness
Map

Whistle

Top trans doctors blowing the whistle on 'sloppy' care

transgender surgery
© Glenn Asakawa/The Denver Post via Getty Images
Dr. Marci Bowers performs gender reassignment surgery in Trinadad’s Mount San Rafael Hospital.
In exclusive interviews, two prominent providers sound off on puberty blockers, 'affirmative' care, the inhibition of sexual pleasure, and the suppression of dissent in their field.

For nearly a decade, the vanguard of the transgender-rights movement — doctors, activists, celebrities and transgender influencers — has defined the boundaries of the new orthodoxy surrounding transgender medical care: What's true, what's false, which questions can and cannot be asked.

They said it was perfectly safe to give children as young as nine puberty blockers and insisted that the effects of those blockers were "fully reversible." They said that it was the job of medical professionals to help minors to transition. They said it was not their job to question the wisdom of transitioning, and that anyone who did — including parents — was probably transphobic. They said that any worries about a social contagion among teen girls was nonsense. And they never said anything about the distinct possibility that blocking puberty, coupled with cross-sex hormones, could inhibit a normal sex life.

Comment: Detrans woman regrets mastectomy: 'Don't indulge young people who think they're trans - many are mentally ill'


Stock Down

Immunity weakens faster in men than women within months of Pfizer's second shot, study finds

Pfizer vaccine
© ANDREJ IVANOV / Bloomberg
A cyclist receives a dose of the Pfizer-BioNTech COVID-19 vaccine at the Gilles Villeneuve racetrack in Montreal, on Saturday, May 29, 2021.
Immunity provided by the COVID-19 vaccine from partners Pfizer Inc. and BioNTech SE weakens significantly within months, with men having less protection than women, according to research that supports the use of booster doses.

Protective antibodies decreased continuously during the six months after the administration of the second dose of the vaccine, according to a study of about 5,000 Israeli health workers, published Wednesday in the New England Journal of Medicine. The levels fell first at a sharp pace and later at a more moderate one.

Researchers worldwide are trying to identify the critical threshold of antibodies needed to prevent coronavirus infection, severe illness and death, said Gili Regev-Yochay, one of the authors of the study. Such studies will help assess risk levels for various groups and the measures needed to protect them, the researcher said.

Antibody levels were found to be lower in older people than in younger, and in immunosuppressed individuals compared to the healthy population, according to the study from Sheba Medical Center in Ramat Gan. Men's antibody counts were lower than those of women both at their peak and at the end of the study.

Syringe

Study shows COVID vaccine does NOT reduce infection as countries with higher vaccination have more cases

VacciNation
In a comparison of 68 countries and 2,947 counties in the U.S., a new study concludes that jurisdictions with high vaccination rates do not have lower infection rates. A recent study just published in the European Journal of Epidemiology demonstrated that vaccination rates did not have an effect on new cases of COVID in the first week of September.

Arrow Down

Covid UK: Cases drop week-on-week for fifth day in a row as deaths fall to 33

Britain covid cases drop September 2021
Covid cases in the UK have dropped for a fifth day in a row, official figures revealed today. Another 35,077 positive tests were recorded across Britain, down 7.6 per cent on last Monday.

The decline follows nearly two weeks of rising infections, fuelled by millions of pupils returning to classrooms last month.

Meanwhile, 33 deaths were registered among people who tested positive for the virus in the last 28 days. It marks a week-on-week drop of 17.5 per cent. No Covid hospitalisation figures were provided for the UK as a whole — but that trend has also been falling.

The fatality figure lags several weeks behind infections because of how long it can take for infected patients to become seriously ill.

Red Flag

Patients with 'red flag' cancer symptoms not referred for urgent investigation in 6 out of 10 cases

pink ribbon breast cancer
Six out of ten patients who show common "alarm" symptoms for cancer are not referred for urgent investigation, a largescale new study has revealed.

The research, led by the University of Exeter working with University College London, and funded by Cancer Research UK, found that a significant number of the patients who were not referred went on to develop cancer within a year of their GP consultation.

One in two people are affected by cancer in their lifetimes, and cancer accounts for nearly 10 million deaths each year worldwide. Early diagnosis is known to be a major factor in saving lives.

SOTT Logo Radio

Objective:Health - The Spartacus Letter

O:H header
On September 24th a mysterious PDF was uploaded online that quickly went viral on social media. Dubbed "The Spartacus Letter", it's a document that outlines almost everything about Covid, from disease function and treatment to revealing the vast criminal conspiracy behind the Covid outbreak. The author of the paper is unknown (although the paper references 'we', indicating there is a group behind it). They make no claim as to their qualifications, although many commentators have said the authors are clearly scientists of some kind, given the level of education and experience clearly evident.

Much of what is stated in the Spartacus Letter is indisputable medical fact about the disease itself, the treatment protocols (successful and unsuccessful), the vaccines, but it also goes into great detail about the criminal conspiracy behind the virus and the thwarting of effective medical treatments.

The authors state the information in the Spartacus Letter is not new - indeed, they say this information has been known for over a year in medical and scientific communities. However, it is extensive and most of those reading it will undoubtedly find something they didn't previously know. Despite its length, and despite the fact that it is unlikely to be entirely true from beginning to end, it is well worth the read.

Join us on this episode of Objective:Health as we discuss the Spartacus Letter.

You can find the letter here: https://www.sott.net/article/458947-The-Spartacus-covid-letter-thats-going-viral

and here: https://mega.nz/file/HZNmyRKB#xF15FrsAEZkwBPi4tdUP5toBBqeRHDJJAHzZt6Hg_Qg


Also check us out on Brighteon!

For other health-related news and more, you can find us on:

♥Twitter: https://twitter.com/objecthealth
♥Facebook: https://www.facebook.com/objecthealth/
♥Brighteon: https://www.brighteon.com/channel/objectivehealth
♥LBRY: https://lbry.tv/@objectivehealth:f
♥Odysee: https://odysee.com/@objectivehealth:f

And you can check out all of our previous shows (pre YouTube) here:

https://docs.google.com/spreadsheets/d/16H-nK-N0ANdsA5JFTT12_HU5nUYRVS9YcQh331dG2MI/edit?usp=sharing

Running Time: 00:39:19

Download: MP3 — 36 MB


Health

Prescribed blood thinners can help reduce hospitalizations related to COVID-19

red blood cells
The NIH has reported that many individuals with COVID-19 develop abnormal blood clots from high inflammation, which can lead to serious health complications and mortality. To find ways to decrease clotting related to COVID-19, researchers from the University of Minnesota and Basel University in Switzerland looked at reducing hospitalizations by using prescribed blood thinners.

"We know that COVID-19 causes blood clots that can kill patients," said lead author Sameh Hozayen, MD, MSC, an assistant professor of medicine at the U of M Medical School. "But, do blood thinners save lives in COVID-19? Blood thinners are medications prescribed to prevent blood clots in patients with a prior blood clot in their lungs or legs. They also prevent blood clots in the brain secondary to abnormal heart rhythms, like atrial fibrillation. Blood thinners are the standard of treatment in these diseases, which is why we looked at data to see if it impacted hospitalizations related to COVID-19."

"We already know that overwhelmed hospitals have a higher risk for death among their patients, so reducing hospitalization may have a positive impact during a COVID-19 surge," Hozayen said.

Published in Lancet's Open Access EClinical Medicine, the study found that:
  • patients on blood thinners before having COVID-19 were admitted less often to the hospital, despite being older and having more chronic medical conditions than their peers;
  • blood thinners — regardless of if they are being used before being infected with COVID-19 or started when admitted to the hospital for treatment of COVID-19 — reduce deaths by almost half; and,
  • hospitalized COVID-19 patients benefit from blood thinners regardless of the type or dose of the medication used.

Health

Delirium recorded in up to 80% of Covid-19 ICU patients

psychology delirium
© yngsa/Getty Images
Patients with COVID-19 who have been admitted to the intensive care unit are very likely to experience unusually persistent delirium, according to emerging research.

Delirium is a medical term used to describe confused thinking and reduced awareness of surroundings - a not uncommon state of mind for the sickest hospitalized patients.

As it turns out, severe cases of COVID-19 are enough to trigger something similar. In fact, initial investigations have suggested delirium occurs in up to 80 percent of ICU patients with COVID-19, possibly as a result of loss of oxygen to the brain or widespread inflammation.

Comment: Whilst it appears there are a number of factors that may have contributed to the rise in delirium, as noted n the article, numerous studies have shown that suffering from Covid does have an impact on the brain and neurological functioning. In addition, the experimental RNA vaccines have also been found to expose one to an increased risk of schizophrenia: RNA Vaccines, Obedience and Eugenics

See also:


Health

India's Most Populous State Eliminates Covid-19 Through Ivermectin (AKA 'Horse Dewormer')

india ivermectin 1
On May 7, 2021, during the peak of India's Delta Surge, The World Health Organization reported, "Uttar Pradesh (is) going the last mile to stop COVID-19."

The WHO noted, "Government teams are moving across 97,941 villages in 75 districts over five days in this activity which began May 5 in India's most populous state with a population of 230 million."

The activity involved an aggressive house-to-house test and treat program with medicine kits.

The WHO explained, "Each monitoring team has two members who visit homes in villages and remote hamlets to test everyone with symptoms of COVID-19 using Rapid Antigen Test kits. Those who test positive are quickly isolated and given a medicine kit with advice on disease management."

The medicines comprising the kit were not identified as part of the Western media blackout at the time. As a result, the contents were as secret as the sauce at McDonald's.


Comment: See also:


Syringe

Russian Health Minister: Sputnik V vaccine may soon receive WHO approval

Sputnik V vaccine
© Lev Vlasov / Keystone Press Agency / Global Look Press
Russia’s Sputnik V vaccine finally set for WHO approval following removal of barriers
Russia's Sputnik V Covid-19 vaccine is finally set to be approved by the WHO after the country's health minister said only 'minor administrative procedures' remain to be finalized following a meeting with the UN agency's chief.

All outstanding issues that had plagued the registration approval process have been resolved between Moscow and the World Health Organization (WHO), Health Minister Mikhail Murashko told TASS on Saturday.

"Russia's position on the promotion and registration of the Russian Sputnik V vaccine has been heard. We have completely resolved all the issues to date," Murashko said. "To date, all the barriers have been removed. Therefore, we do not see any obstacles to further work today. And this was confirmed to us by the WHO director general."